Condition: Bipolar I or II Disorder · Sponsor: AbbVie
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. The purpose of this study is to assess how safe and effective ABBV-932 is in treating participants with depressive episodes associated with bipolar I or II disorder. ABBV-932 is an investigational drug being developed for the treatment of depressive episodes in adult participants with bipolar I or II disorder. Participants with bipolar I or II disorder who are currently experiencing a depressive episode will enter the study and be treated with open-label ABBV-932. Approximately 200 adult participants with bipolar I or II disorder will be enrolled in approximately 50 sites in the United States and Puerto Rico. Participants will receive oral capsules of ABBV-932 for a 26-week treatment period. The treatment period will be followed by a safety follow-up (SFU) period of 30 days. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regularly scheduled visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
This description comes directly from the study's public registry record.
ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com
Always discuss trial participation with your own doctor first.
| Ima Clinical Research Phoenix (Alea) /ID# 278047 | Phoenix, Arizona, United States | Recruiting |
| Advanced Research Center /ID# 273474 | Anaheim, California, United States | Recruiting |
| Axiom Research /ID# 273482 | Colton, California, United States | Recruiting |
| Collaborative Neuroscience Research - Garden Grove /ID# 273492 | Garden Grove, California, United States | Recruiting |
| Sun Valley Research Center /ID# 273472 | Imperial, California, United States | Recruiting |
| Synergy San Diego /ID# 278340 | Lemon Grove, California, United States | Recruiting |
| Alliance for Research Alliance for Wellness /ID# 273477 | Long Beach, California, United States | Recruiting |
| Nrc Research Institute - Los Angeles /ID# 278450 | Los Angeles, California, United States | Recruiting |
| Excell Research /ID# 273483 | Oceanside, California, United States | Recruiting |
| Inland Psychiatric Medical Group /ID# 273471 | Temecula, California, United States | Recruiting |
| Sunwise Clinical Research /ID# 278165 | Walnut Creek, California, United States | Recruiting |
| Connecticut Clinical Research - Cromwell /ID# 278116 | Cromwell, Connecticut, United States | Recruiting |
+ 37 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07220460